학술논문
Doxorubicin, paclitaxel, and cisplatin (ATP) for refractory germ cell tumors.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe17028-e17028, 1p
Subject
Language
ISSN
0732183X